Clover Biopharmaceuticals Ltd. (HK:2197)

:2197

2197

Clover Biopharmaceuticals Ltd.

RESEARCH TOOLSreports

Want to see HK:2197 full AI Analyst Report?

Compare Clover Biopharmaceuticals Ltd. (2197) vs. Competitors

1 Followers

Comparison Results

2197

Clover Biopharmaceuticals Ltd.

HK$2.37

HK$3.32B

-6.73

944.90%

―

Kintor Pharmaceutical Ltd

HK$1.92

HK$1.29B

-3.96

83.92%

―

HBM Holdings Ltd.

HK$12.08

HK$10.79B

13.52

32.79%

2 Buy

0 Hold

0 Sell

Moderate Buy

Jiangsu Recbio Technology Co., Ltd. Class H

HK$4.18

HK$3.87B

-3.21

-40.94%

―

Sirnaomics Ltd.

HK$8.00

HK$607.86M

-2.18

78.71%

―

Transcenta Holding Limited

HK$2.25

HK$868.22M

―

33.56%

―

xxxxxxxxxxxxx

2197 vs 6628

xxxxxxxxxxxxx

Performance Comparison

HK:2197

Clover Biopharmaceuticals Ltd.

2.56

2.31

924.00%

HK:9939

Kintor Pharmaceutical Ltd

2.63

1.22

86.52%

HK:2142

HBM Holdings Ltd.

12.15

3.75

44.64%

HK:2179

Jiangsu Recbio Technology Co., Ltd. Class H

5.15

-3.24

-38.62%

HK:2257

Sirnaomics Ltd.

5.54

2.41

77.00%

HK:6628

Transcenta Holding Limited

1.95

0.55

39.29%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >